Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Tenaya Therapeutics Approves Restructuring Plan; Restructuring Plan To Reduce Cash Expenses; Restructuring Plan To Extend Cash Runway Into H2 2026; To Reduce Workforce Under Restructuring Plan; To Incur $1.6M-$2.7M In Restructuring Charges; Expects To Recognize Charges By Q3 2025

Author: Benzinga Newsdesk | March 28, 2025 04:44pm

- SEC Filing

Posted In: TNYA